Gyre Therapeutics, Inc.
$6.47
-0.10 (-1.52%)
Price as of Sep 01, 2026 market close
Performance
- 1 Month
- +5.9%
- 3 Months
- +16.4%
- YTD
- -8.4%
- 1 Year
- -16.4%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 57.3%
- Largest decline max drawdown, since Aug 2025
- -37.3%
- Risk-adjusted return Sharpe ratio, 1-year
- -0.03
Own GYRE?
See how GYRE contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.